SCTX
Scribe Therapeutics Inc.
$27.11
+5.92
(+27.94%)
Mkt Cap
438.69M
Volume
501,664
52W Range
17.31-27.75
Sector
Healthcare
Beta
0.00
EPS (TTM)
N/A
P/E Ratio
N/A
Revenue (TTM)
N/A
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
SCTX News
